îæ€çŽ¢
îæ€çŽ¢
î
Aligos Therapeutics Inc
ALGSîãŠã©ãããªã¹ãã«è¿œå
6.705USD
-0.185-2.69%
ååŒæé ïŒETïŒ15åé
ãã®æ ªäŸ¡
41.82Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
äºæž¬å€
é貚: USD æŽæ°æå»: 2026-08-14Aligos Therapeutics Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.25ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯387瀟äž149äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯55.00ã§ãæé«ã¯175.00ãæäœã¯36.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
8
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
54.875
ç®æšæ ªäŸ¡
+696.44%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
497
åèš
6
äžå€®å€
7
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Aligos Therapeutics Inc
ALGS
8
argenx SE
ARGX
28
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
Aligos Therapeutics Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îAligos Therapeutics Inc ã®äºæ³åç㯠1.11M ã§ãã
Aligos Therapeutics Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãAligos Therapeutics Inc ã®ç®æšæ ªäŸ¡ã USD 55.00 ãšäºæ³ããæé«äºæ³ã¯ USD 175.00ãæäœäºæ³ã¯ USD 36.00 ãšäºæ³ããŠããŸãã
Aligos Therapeutics IncALGS ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.14 ã§ããããAligos Therapeutics IncALGS ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -2.21 ã§ããã次ã®ååæã® EPS 㯠USD -2.16 ãšäºæ³ãããŸãã
Aligos Therapeutics Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î8 ã¢ããªã¹ãã«ãã Aligos Therapeutics Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Aligos Therapeutics Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã